Fractyl Health Reports 3-Month REVEAL-1 Data Suggesting Durable Weight Maintenance, Stock Down
23/6 17:31
(RTTNews) - Fractyl Health (GUTS), Monday released 3-month results from the open-label REVEAL-1 Cohort of its REMAIN-1 pivotal trial, showing its Revita procedure may sustain weight loss after stopping GLP-1 therapy....